tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
GYRE
Gyre Therapeutics
RESEARCH TOOLSreports

Gyre Therapeutics (GYRE) Ratios

827 Followers

Gyre Therapeutics Ratios

GYRE's free cash flow for Q4 2025 was $0.95. For the 2025 fiscal year, GYRE's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.60 5.60 3.32 2.85 4.06
Quick Ratio
 5.04 5.04 2.99 2.64 3.56
Cash Ratio
 2.03 2.03 0.61 1.67 2.06
Solvency Ratio
 0.32 0.32 0.51 -0.90 0.27
Operating Cash Flow Ratio
 0.06 0.06 -0.19 1.29 0.87
Short-Term Operating Cash Flow Coverage
 1.59 1.59 0.00 0.00 0.00
Net Current Asset Value
$ 78.52M$ 78.52M$ 37.78M$ -45.37M$ 37.12M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.03 -0.03 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 0.02 -0.03 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.57 1.57 1.98 -7.36 1.99
Debt Service Coverage Ratio
 15.97 29.19 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.01 0.01 0.02 <0.01 <0.01
Net Debt to EBITDA
 -2.46 -2.58 -0.57 -1.63 -2.38
Profitability Margins
Gross Profit Margin
95.35%95.35%96.33%95.91%95.31%
EBIT Margin
10.46%9.86%15.35%16.94%9.00%
EBITDA Margin
12.62%12.02%16.85%17.92%10.10%
Operating Profit Margin
9.85%9.85%15.28%-59.26%9.00%
Pretax Profit Margin
12.38%12.38%21.95%-67.84%9.20%
Net Profit Margin
4.31%4.31%11.43%-81.92%2.25%
Continuous Operations Profit Margin
8.47%8.47%16.92%-75.35%4.22%
Net Income Per EBT
34.82%34.82%52.05%120.75%24.46%
EBT Per EBIT
125.65%125.67%143.65%114.48%102.27%
Return on Assets (ROA)
3.03%3.03%9.64%-79.74%2.72%
Return on Equity (ROE)
5.46%4.74%19.09%587.14%5.41%
Return on Capital Employed (ROCE)
7.77%7.77%15.26%-69.67%12.69%
Return on Invested Capital (ROIC)
5.30%7.74%11.69%-69.52%5.78%
Return on Tangible Assets
3.11%3.11%9.77%-80.92%2.78%
Earnings Yield
0.75%0.80%1.17%-5.93%0.38%
Efficiency Ratios
Receivables Turnover
 3.16 3.16 3.63 6.74 6.55
Payables Turnover
 43.68 43.68 35.96 13.06 39.29
Inventory Turnover
 0.53 0.53 0.61 1.08 0.78
Fixed Asset Turnover
 4.71 4.71 4.12 4.77 5.57
Asset Turnover
 0.70 0.70 0.84 0.97 1.21
Working Capital Turnover Ratio
 1.40 1.80 2.57 3.04 2.74
Cash Conversion Cycle
 792.76 792.76 685.99 363.28 512.63
Days of Sales Outstanding
 115.67 115.67 100.62 54.18 55.72
Days of Inventory Outstanding
 685.45 685.45 595.52 337.05 466.21
Days of Payables Outstanding
 8.36 8.36 10.15 27.95 9.29
Operating Cycle
 801.12 801.12 696.14 391.23 521.92
Cash Flow Ratios
Operating Cash Flow Per Share
 0.01 0.01 -0.04 0.39 0.14
Free Cash Flow Per Share
 -0.01 >-0.01 -0.08 0.26 0.07
CapEx Per Share
 0.02 0.01 0.04 0.13 0.07
Free Cash Flow to Operating Cash Flow
 -0.91 -0.18 1.86 0.67 0.53
Dividend Paid and CapEx Coverage Ratio
 0.52 0.85 -1.16 0.11 <0.01
Capital Expenditure Coverage Ratio
 0.52 0.85 -1.16 3.02 2.14
Operating Cash Flow Coverage Ratio
 1.08 1.08 -2.28 63.31 17.42
Operating Cash Flow to Sales Ratio
 <0.01 <0.01 -0.03 0.23 0.10
Free Cash Flow Yield
-0.14%-0.03%-0.66%1.11%0.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 134.01 125.48 85.20 -16.85 265.01
Price-to-Sales (P/S) Ratio
 5.79 5.41 9.74 13.80 5.96
Price-to-Book (P/B) Ratio
 6.35 5.95 16.26 -98.95 14.35
Price-to-Free Cash Flow (P/FCF) Ratio
 -735.89 -3.50K -152.11 90.50 107.42
Price-to-Operating Cash Flow Ratio
 666.97 624.53 -282.79 60.49 57.14
Price-to-Earnings Growth (PEG) Ratio
 0.89 -2.10 -0.78 <0.01 -2.62
Price-to-Fair Value
 6.35 5.95 16.26 -98.95 14.35
Enterprise Value Multiple
 43.41 42.44 57.22 75.42 56.67
Enterprise Value
 638.68M 594.64M 1.02B 1.53B 585.49M
EV to EBITDA
 43.41 42.44 57.22 75.42 56.67
EV to Sales
 5.48 5.10 9.64 13.51 5.72
EV to Free Cash Flow
 -696.49 -3.30K -150.60 88.58 103.10
EV to Operating Cash Flow
 632.36 588.75 -279.99 59.21 54.84
Tangible Book Value Per Share
 1.51 1.54 1.14 0.19 0.92
Shareholders’ Equity Per Share
 1.16 1.19 0.74 -0.24 0.55
Tax and Other Ratios
Effective Tax Rate
 0.32 -0.32 0.23 -0.11 0.54
Revenue Per Share
 1.28 1.30 1.24 1.72 1.33
Net Income Per Share
 0.06 0.06 0.14 -1.41 0.03
Tax Burden
 0.35 0.35 0.52 1.21 0.24
Interest Burden
 1.18 1.26 1.43 -4.01 1.02
Research & Development to Revenue
 0.12 0.12 0.11 0.12 0.16
SG&A to Revenue
 0.74 0.74 0.70 0.13 0.17
Stock-Based Compensation to Revenue
 0.06 0.06 <0.01 0.06 0.13
Income Quality
 0.11 0.10 -0.20 -0.30 2.47
Currency in USD